Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer (Q42954285)

11 November 2017

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer (English)

1 reference

11 November 2017

Won-Suk Lee

1

1 reference

11 November 2017

Sanghui Park

2

1 reference

11 November 2017

Woo Yong Lee

3

1 reference

11 November 2017

Seong Hyeon Yun

4

1 reference

11 November 2017

Ho-Kyung Chun

5

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

11 November 2017

1 reference

11 November 2017

116

1 reference

11 November 2017

22

1 reference

11 November 2017

5188-5199

1 reference

11 November 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Cancer Incidence in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

National Surgical Adjuvant Breast and Bowel Project trials in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Survival of patients with stage B2 colon carcinoma. The Gastrointestinal Tumor Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Adjuvant therapy in stage II colon cancer: current approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Foxp3: a critical regulator of the development and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Lymphocytic infiltration and survival in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Lymphoid infiltration and prognosis in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

A new prognostic classification of rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

7 January 2021

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

7 January 2021

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

7 January 2021

Regulatory T-cell development: is Foxp3 the decider?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

7 January 2021

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25293

7 January 2021

Identifiers

DOI

10.1002/CNCR.25293

1 reference

11 November 2017

1 reference